Thousands of men in England diagnosed with low- and intermediate-risk prostate cancer will soon access stereotactic ablative radiotherapy (SABR), a precision treatment that reduces the required sessions from 20 to five. NHS England reports all 48 national radiotherapy centres will offer the procedure within weeks, marking the first time this high-powered technique is available outside … Read more
The Invisible Threat: Why Standard Scans Are Failing Prostate Cancer Patients Imagine receiving a report from your doctor stating that your bone scan is perfectly clear. You breathe a sigh of relief, thinking the cancer is contained. But beneath the surface, a silent progression is already underway. This is the harrowing reality for a significant … Read more
Revolutionizing Prostate Cancer Care: The Future of Personalized Radiotherapy For patients battling metastatic castration-resistant prostate cancer (mCRPC), the path to effective treatment is often complex. A breakthrough in machine learning is now offering a glimpse into a more precise future, where clinicians can estimate radiation doses to tumors and healthy organs before therapy even begins. … Read more
The Future of Prostate Cancer Treatment: Breaking the Cycle of Therapy Resistance Prostate cancer remains a formidable challenge in global health, with its complexity evolving alongside the very treatments designed to combat it. A recent review published in the journal Research (DOI: 10.34133/research.1128) sheds new light on the mechanisms driving therapy resistance, providing a roadmap … Read more
The Shift Toward Ultra-Hypofractionated Radiotherapy For decades, the standard approach to treating localized prostate cancer involved a grueling schedule of daily hospital visits. In many countries, the benchmark has been five radiotherapy sessions. However, a significant shift is occurring toward “hypofractionation”—delivering larger doses of radiation in fewer sessions. Recent findings from the HERMES study, presented … Read more
The New Frontier of Cancer Care: Why Epigenetics is a Game Changer For decades, the fight against cancer was primarily a battle over genetics—the fixed “blueprint” of our DNA. If a mutation occurred in a specific gene, the result was often a cellular malfunction that led to tumor growth. But a paradigm shift is occurring … Read more
The Era of Vulnerable Leadership: Breaking the Silence on Health For decades, the archetype of a global leader was one of perceived invincibility. However, we are witnessing a fundamental shift toward “vulnerable leadership.” When high-profile figures, such as King Charles III, speak openly about their health journeys—including a cancer diagnosis—it transforms the public’s relationship with … Read more
Starving the Tumor: The Rise of Bacterial-Inspired Cancer Therapies For decades, the war on cancer has largely focused on attacking the cell’s ability to divide. But, a paradigm shift is occurring. Researchers are now looking at how to “starve” cancer by targeting its energy source: the mitochondria. View this post on Instagram about Starving the … Read more
Prime Minister Benjamin Netanyahu has received a clean bill of health following the successful treatment of early-stage prostate cancer. The news was revealed for the first time in an official medical report released by the Prime Minister’s Office on Friday. Did You Know? The cancer was first detected during a routine follow-up MRI, which identified … Read more
Expanding the Horizon of Personalized Oncology For years, the medical community has viewed BRCA1 and BRCA2 mutations primarily through the lens of breast and ovarian cancer risk. However, a groundbreaking shift is occurring in how we understand genetic susceptibility. Recent research led by the RIKEN Center for Integrative Medical Sciences (IMS) in Japan is pushing … Read more